The Tox

Should you invest $236,000 to $448,000 in a lymphatic drainage and body sculpting studio? That is the precise question thousands of wellness entrepreneurs are asking about The Tox franchise, a category-creating brand that launched in Los Angeles in April 2019 and has since grown into one of the fastest-expanding concepts in the U.S. wellness industry. Founded by Courtney Yeager, who serves as CEO, alongside her husband Ryan Yeager as COO, The Tox was built on a singular conviction: that lymphatic drainage — long the domain of medical spas and exclusive treatment centers — could be productized, systematized, and delivered at scale through a community-driven studio format. The company's first location opened in Los Angeles in April 2019, and within four years, Yeager had established 12 corporate locations before pivoting aggressively to franchising, ultimately awarding 150 territories nationwide and projecting more than 100 additional studio openings within 18 months of March 2026. The Tox operates within the U.S. health and wellness sector, estimated at $20 billion domestically, while the broader global wellness and detox market is projected to reach $70 billion by 2027, compounding at an 8% CAGR from 2022. The brand earned recognition as an Inc. 5000 honoree in 2025, ranking No. 1902 overall with a 229% three-year revenue growth rate, and separately ranked No. 84 in the Regionals Southeast category for 2025. With 50 studios currently open as of March 2026 and a partnership with Franchise FastLane as its franchise sales organization, The Tox franchise opportunity sits at a rare intersection of early-stage growth and proven consumer demand. This analysis is produced independently by PeerSense and is not sponsored by or affiliated with The Tox corporate or any franchise broker.

The industry backdrop for The Tox franchise investment is exceptionally favorable when examined through multiple lenses of market data. The U.S. health and wellness sector stands at an estimated $20 billion, but The Tox competes across a broader opportunity set: the personal care and beauty segment, valued at $310 billion globally, grew 13.4% between 2020 and 2022 according to the Global Wellness Institute, a period that included significant pandemic-era disruption. The wellness and detox market specifically is projected to reach $70 billion by 2027, representing an 8% compound annual growth rate from 2022, which exceeds the growth rates of most consumer discretionary categories. Three secular tailwinds are converging to drive demand for services like The Tox: first, rising consumer awareness of lymphatic health and its connection to inflammation, immune function, and body composition; second, a documented shift toward non-invasive body contouring as consumers reject surgical procedures in favor of result-oriented wellness treatments; and third, a broader cultural movement toward holistic, toxin-free self-care that is reshaping how Americans spend discretionary health and beauty dollars. Consumer demand for non-invasive body contouring is steadily increasing across all major U.S. metropolitan markets, and The Tox's proprietary technique is designed specifically to address water retention, excess toxins, bloating, and body sculpting — outcomes that consumers are actively searching for through health-adjacent beauty services. The competitive landscape for lymphatic drainage franchises remains fragmented, with few if any national franchise chains offering the systematic, studio-based approach that The Tox has pioneered, giving early-stage franchise investors a genuine first-mover advantage in their local markets. The brand explicitly positions itself as a first-to-market franchise concept, not a traditional spa but a community-oriented studio with black-and-white branding, upbeat music, and curtained treatment spaces rather than individual rooms — a format differentiation that resonates strongly with millennial and Gen Z wellness consumers who prioritize community and authenticity over clinical environments.

The Tox franchise cost structure is well-defined and positions the brand within the accessible-to-mid-tier range of wellness franchise investments. The franchise fee is $49,500, which grants an exclusive protected territory and access to the full system including proprietary training, marketing infrastructure, and the brand's internal manufacturing group. Total initial investment ranges from $236,000 to $448,000 depending on market, build-out specifications, real estate conditions, and geographic location — with the variance in the range driven primarily by leasehold improvement costs, which fluctuate significantly between high-rent coastal markets and lower-cost interior U.S. markets. This investment covers leasehold improvements, furniture and fixtures, equipment, initial inventory, and working capital, providing franchisees with a complete turnkey studio. Liquid capital required is $200,000, and the net worth requirement is $450,000, placing The Tox franchise investment within reach of serious individual investors and small investment groups without requiring institutional backing. The ongoing royalty rate is 8% of gross revenue, and franchisees pay an additional 2% marketing fee based on gross revenue, bringing the total ongoing fee burden to 10% of gross sales — a figure that is on the higher end of the wellness franchise category but is partially offset by the corporate team's management of influencer campaigns and social media marketing, which would otherwise represent a significant out-of-pocket operating cost for independent studio operators. Multi-unit investors face a modestly different investment profile, with a range of $288,000 to $497,000 for multi-location deals, reflecting economies of scale in some areas while also accounting for the added working capital demands of scaling across geographies. Financing is available through The Tox's franchise offering, an important consideration given that the $200,000 liquid capital threshold may represent a meaningful portion of many investors' accessible capital. For context, working capital alone is specified at between $10,000 and $30,000 within the total investment range, suggesting a relatively lean operational startup cost structure once real estate and build-out costs are accounted for. The brand's partnership with Franchise FastLane streamlines the discovery and qualification process, though prospective investors should conduct independent financial due diligence before signing any franchise agreement.

Daily operations at a The Tox studio are structured around a lean, appointment-driven service model that gives this franchise concept meaningfully different unit economics than traditional service businesses. The studio can be operated with a lean staff of four to five employees, and the technician role is filled by estheticians rather than licensed massage therapists — a critical staffing distinction that expands the available labor pool and reduces the wage pressure that constrains margins at competing body treatment concepts. Franchisees undergo a 50-hour online training program as the foundation of their preparation, followed by an intensive in-person training experience working in a busy corporate studio in New York, specifically locations such as Soho, for three to five days until proficiency is demonstrated across all studio operations. The training pathway for technicians is notably rigorous: approximately 60% of technician candidates successfully complete the certification program, which ensures service quality consistency across the national network but also means franchisees should plan for a broader initial recruitment pool when staffing new locations. The corporate team provides site selection assistance and lease negotiation support, reducing the friction and risk associated with securing real estate, which is often the single most consequential early decision in any retail or studio franchise. Marketing support at The Tox is unusually robust: the corporate team executes and manages a turnkey influencer and social media marketing program on behalf of each franchisee, and every franchisee is assigned a personal social media manager who identifies 20 local influencers in their community to drive awareness and bookings before and after grand opening. Franchisees also receive on-site field operations support and access to technology systems that manage appointment scheduling and client communications, and The Tox's internal manufacturing group produces all proprietary supplies and the toxin-free "The Tox Shop" product line in-house, eliminating third-party supply chain risk. Territory protection is exclusive, providing franchisees with geographic security as the national network continues to scale. After the first year of operation, many owners have the potential to install a general manager and transition toward a semi-passive ownership model, creating a pathway to multi-unit expansion or other investment activities.

The Tox financial performance data presents a compelling unit economics picture, though investors must navigate some variation in the figures reported across different sources and time periods. In 2025, the company reported average annual revenue of $1,120,458 with an average earnings margin of 28.4% across franchise locations — translating to approximately $318,210 in average annual earnings per studio at that revenue level. A separate data point reports average studio revenue of $1.2 million with $326,000 in average earnings, while another set of figures cites average gross revenue of $997,000 and adjusted net income of $257,000, yielding a 25.8% adjusted margin. Taken together, these figures suggest a revenue range between approximately $997,000 and $1.2 million for a mature studio, with owner earnings in the $257,000 to $326,000 range depending on market, operational efficiency, and revenue volume. The average ticket price of $290 per service is a significant unit economics driver: at $290 per client visit, a studio generating $1,120,458 in annual revenue requires approximately 3,863 service transactions per year, or roughly 74 appointments per week across a 52-week operating year — a realistic throughput target for a four-to-five person team operating in a community with strong demand. Critically, The Tox requires clients to pay at the time of scheduling rather than at the point of service, which measurably reduces appointment cancellations and no-shows — a structural cash flow advantage that most service businesses lack and that contributes to revenue predictability. The proprietary "The Tox Shop" product line represents an additional revenue stream, with projected annual growth of 3.8% through 2025, providing franchisees with retail margin on top of service revenue. Payback period analysis based on the midpoint investment of approximately $342,000 and average earnings of approximately $290,000 suggests a theoretical pre-tax payback period of roughly 14 months at average performance — a figure that warrants independent verification through franchisee interviews and audited financial statements during the due diligence process.

The Tox franchise growth trajectory is one of the most rapid in the modern wellness franchise category and warrants careful analysis by any investor evaluating the brand's long-term network stability and support infrastructure scalability. The company established 12 corporate locations between 2019 and 2023 entirely through organic growth, providing proof of concept before franchising began. An agreement from August 2023 set a target of a minimum of 75 franchises across the United States within three years — a goal the brand has arguably already exceeded given that 150 territories have been awarded as of March 2026, with 50 studios currently open and more than 100 additional locations scheduled to open within the next 18 months. The brand's Inc. 5000 recognition in 2025 at No. 1902, reflecting 229% three-year revenue growth, provides third-party validation of the organization's financial momentum at the corporate level. Franchise FastLane's involvement as the franchise sales organization accelerates territory awards and franchisee qualification, which is both a growth accelerator and an area of due diligence attention — rapid unit count growth must be supported by proportional growth in field operations, training capacity, and franchisee support staffing to avoid the support dilution that has undermined faster-growing wellness franchises in prior market cycles. The brand's competitive moat is multifaceted: its proprietary lymphatic drainage technique differentiates it from generic spa services, its internal manufacturing group for supplies and the Tox Shop product line creates supply chain control, its turnkey influencer marketing program is a genuine operational advantage that most franchisors of this size cannot replicate, and its first-to-market positioning in the lymphatic drainage studio category means early franchisees face limited branded competition in most U.S. markets. The brand is actively accepting inquiries from 41 states including AZ, FL, TX, GA, NC, TN, CO, OH, PA, and many others, suggesting substantial available white space for territory development. Leadership stability — with founder Courtney Yeager as CEO and Ryan Yeager as COO — provides strategic continuity as the brand scales.

The ideal The Tox franchise candidate is someone with a genuine passion for the wellness and beauty industries, strong community engagement skills, and the financial profile to meet the $200,000 liquid capital and $450,000 net worth requirements. Prior experience in health, beauty, retail, or service business management is advantageous, though not necessarily required given the comprehensive 50-hour online training program and the intensive in-person New York studio immersion experience. The brand's staffing model — relying on estheticians rather than massage therapists, and operating with four to five total employees — makes this a manageable owner-operator business in year one, with a clear evolution path to semi-passive management through a general manager hire in year two or beyond, which is an explicit feature of the operational model. Multi-unit opportunities are available, with the multi-unit investment range of $288,000 to $497,000 providing a structured pathway for investors who want to build a portfolio of locations from the outset rather than proving the concept in a single market first. Geographic availability spans 41 states, with The Tox's established presence in Arizona, Florida, Nevada, and Texas providing a proof-of-concept track record in Sun Belt markets that tend to have strong wellness consumer spending and favorable commercial real estate conditions. The timeline from franchise agreement signing to studio opening depends on site selection, lease negotiation, and build-out duration, with corporate support provided at each stage to compress the pre-opening period. Exclusive territory protection ensures that franchisees who invest early in a market are insulated from same-brand competition as the network scales toward and beyond 100 open locations.

The Tox franchise opportunity presents a genuinely differentiated investment thesis within the $70 billion global wellness and detox market: a founder-led, category-creating brand with documented average annual revenues approaching $1.2 million per mature studio, margins in the 25.8% to 28.4% range, a lean four-to-five person staffing model, a $290 average service ticket, and a growth trajectory that produced 229% revenue expansion over three years and 150 awarded territories by March 2026. The combination of first-to-market positioning in the lymphatic drainage studio category, a proprietary service technique, an internal manufacturing group for supplies, a turnkey influencer marketing program managed by the corporate team, and exclusive territory protection creates a franchise system with structural advantages that most wellness concepts at this stage of development do not possess. Investors conducting serious due diligence on The Tox should examine the franchise disclosure document carefully, speak with existing franchisees across multiple markets, and analyze the support infrastructure's capacity to serve 100-plus new locations opening within an 18-month window. PeerSense provides exclusive due diligence data including SBA lending history, FPI scores, location maps with Google ratings, FDD financial data, and side-by-side comparison tools that allow investors to benchmark The Tox against competing wellness franchise opportunities on a normalized, data-driven basis — capabilities that no other franchise research platform offers at this level of depth. The Tox carries a PeerSense FPI Score of 65, classified as Strong, reflecting the brand's growth momentum, disclosed financial performance, and market positioning within the wellness franchise category. Explore the complete The Tox franchise profile on PeerSense to access the full suite of independent franchise intelligence data and make the most informed investment decision possible.